These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28679637)

  • 1. Mechanism-based inactivator of isocitrate lyases 1 and 2 from
    Pham TV; Murkin AS; Moynihan MM; Harris L; Tyler PC; Shetty N; Sacchettini JC; Huang HL; Meek TD
    Proc Natl Acad Sci U S A; 2017 Jul; 114(29):7617-7622. PubMed ID: 28679637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism-Based Inactivation of
    Mellott DM; Torres D; Krieger IV; Cameron SA; Moghadamchargari Z; Laganowsky A; Sacchettini JC; Meek TD; Harris LD
    J Am Chem Soc; 2021 Oct; 143(42):17666-17676. PubMed ID: 34664502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Covalent Inactivation of
    Pham TV; Mellott DM; Moghadamchargari Z; Chen K; Krieger I; Laganowsky A; Sacchettini JC; Meek TD
    ACS Chem Biol; 2021 Mar; 16(3):463-470. PubMed ID: 33688722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solvent isotope-induced equilibrium perturbation for isocitrate lyase.
    Quartararo CE; Hadi T; Cahill SM; Blanchard JS
    Biochemistry; 2013 Dec; 52(51):9286-93. PubMed ID: 24261638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneous multimeric structure of isocitrate lyase in complex with succinate and itaconate provides novel insights into its inhibitory mechanism.
    Kwon S; Chun HL; Ha HJ; Lee SY; Park HH
    PLoS One; 2021; 16(5):e0251067. PubMed ID: 33951112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of isocitrate lyase, a persistence factor of Mycobacterium tuberculosis.
    Sharma V; Sharma S; Hoener zu Bentrup K; McKinney JD; Russell DG; Jacobs WR; Sacchettini JC
    Nat Struct Biol; 2000 Aug; 7(8):663-8. PubMed ID: 10932251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demystifying the catalytic pathway of Mycobacterium tuberculosis isocitrate lyase.
    Ibeji CU; Salleh NAM; Sum JS; Ch'ng ACW; Lim TS; Choong YS
    Sci Rep; 2020 Nov; 10(1):18925. PubMed ID: 33144641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
    Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
    Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Nitro Group as a Masked Electrophile in Covalent Enzyme Inhibition.
    Ray S; Kreitler DF; Gulick AM; Murkin AS
    ACS Chem Biol; 2018 Jun; 13(6):1470-1473. PubMed ID: 29782144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-function insights into elusive Mycobacterium tuberculosis protein Rv1916.
    Antil M; Sharma J; Brissonnet Y; Choudhary M; Gouin S; Gupta V
    Int J Biol Macromol; 2019 Dec; 141():927-936. PubMed ID: 31505209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cysteine is the general base that serves in catalysis by isocitrate lyase and in mechanism-based inhibition by 3-nitropropionate.
    Moynihan MM; Murkin AS
    Biochemistry; 2014 Jan; 53(1):178-87. PubMed ID: 24354272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual role of isocitrate lyase 1 in the glyoxylate and methylcitrate cycles in Mycobacterium tuberculosis.
    Gould TA; van de Langemheen H; Muñoz-Elías EJ; McKinney JD; Sacchettini JC
    Mol Microbiol; 2006 Aug; 61(4):940-7. PubMed ID: 16879647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential inhibitors for isocitrate lyase of Mycobacterium tuberculosis and non-M. tuberculosis: a summary.
    Lee YV; Wahab HA; Choong YS
    Biomed Res Int; 2015; 2015():895453. PubMed ID: 25649791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active Site Flexibility of Mycobacterium tuberculosis Isocitrate Lyase in Dimer Form.
    Lee YV; Choi SB; Wahab HA; Choong YS
    J Chem Inf Model; 2017 Sep; 57(9):2351-2357. PubMed ID: 28820943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence.
    Muñoz-Elías EJ; McKinney JD
    Nat Med; 2005 Jun; 11(6):638-44. PubMed ID: 15895072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetyl-CoA-mediated activation of Mycobacterium tuberculosis isocitrate lyase 2.
    Bhusal RP; Jiao W; Kwai BXC; Reynisson J; Collins AJ; Sperry J; Bashiri G; Leung IKH
    Nat Commun; 2019 Oct; 10(1):4639. PubMed ID: 31604954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applications of Ensemble Docking in Potential Inhibitor Screening for Mycobacterium tuberculosis Isocitrate Lyase Using a Local Plant Database.
    Lee YV; Choi SB; Wahab HA; Lim TS; Choong YS
    J Chem Inf Model; 2019 May; 59(5):2487-2495. PubMed ID: 30840452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-based screening and molecular dynamics simulations offer novel natural compounds as potential inhibitors of Mycobacterium tuberculosis isocitrate lyase.
    Shukla R; Shukla H; Sonkar A; Pandey T; Tripathi T
    J Biomol Struct Dyn; 2018 Jun; 36(8):2045-2057. PubMed ID: 28605994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the
    Ko EM; Kim JY; Lee S; Kim S; Hwang J; Oh JI
    J Bacteriol; 2021 Nov; 203(23):e0040221. PubMed ID: 34516281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity loss by H46A mutation in Mycobacterium tuberculosis isocitrate lyase is due to decrease in structural plasticity and collective motions of the active site.
    Shukla R; Shukla H; Tripathi T
    Tuberculosis (Edinb); 2018 Jan; 108():143-150. PubMed ID: 29523315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.